Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
EBITDA Over TimeContracting
Percentile Rank13
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-33.78M
↓ 12% vs avg
Percentile
P13
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-30.06M
Historical baseline
PeriodValueYoY Change
TTM$-33.78M+9.8%
2024$-37.43M+26.8%
2023$-51.13M-53.1%
2022$-33.41M-37.8%
2021$-24.25M-11.4%
2020$-21.77M-1.3%
2019$-21.48M+9.7%
2018$-23.78M+11.5%
2017$-26.86M-0.3%
2016$-26.77M-